Pharmacy Times
AUGUST 23, 2023
By embracing collaboration, optimizing work hours, and prioritizing patient care, pharmacy technicians are leading the charge towards an inclusive, technologically advanced, and patient-focused era in pharmaceutical practice.
Drug Topics
AUGUST 25, 2023
The new deadline to be in compliance with the requirements will be November 27, 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 25, 2023
With last fall’s chaotic early start to the respiratory virus season still fresh in the public memory, federal health authorities are trying to move quickly to convey the impression that this year will be different. In a briefing for reporters Thursday, senior officials of the Centers for Disease Control and Prevention and the Food and Drug Administration detailed the various countermeasures available to combat Covid-19, RSV, and influenza, and discussed the expected timing on the rollout
Drug Store News
AUGUST 25, 2023
The powdered drink mixes—available in Lemonade and Berry Medley flavors—are infused with 25 mg of 100% CBD per serving.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
AUGUST 25, 2023
The drug can now be tested for safety, tolerability, and efficacy in a phase 1 study.
Drug Topics
AUGUST 25, 2023
A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
European Pharmaceutical Review
AUGUST 25, 2023
A paper published in Molecules has detailed a strategy and evaluation approach for acceptable classification of species usually detected in migration studies. This can therefore support extractable and leachable (E&L) studies. Migration studies are one of the few domains of QA/QC pharmaceutical analysis employing wide-scope screening methodologies, the paper noted.
Pharmacy Times
AUGUST 25, 2023
Investigators determined that there needs to be an evaluation of harm caused by pharmacy professionals who are in unique positions on social media, propagating misinformation about COVID-19, vaccines, treatment, masks, and other conspiracy theories.
Drug Topics
AUGUST 23, 2023
The CDC and WHO are currently tracking several variants that are driving the majority of new cases around the world.
Fierce Pharma
AUGUST 25, 2023
Add another failed trial to the list of setbacks for Merck and Eisai’s combination of Keytruda and Lenvima. | Add another failed trial to the list of setbacks for Merck and Eisai’s combination of Keytruda and Lenvima. The companies have decided to shut down a phase 3 study testing the PD-1/TKI combo in first-line head and neck cancer.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
AUGUST 25, 2023
The European Commission (EC)’s revised Annex 1 – Manufacture of Sterile Medicinal Products is now effective in the EU. As of 25 August 2023, pharmaceutical manufacturers are required to implement the GMP regulation into cleaning and bio-decontamination procedures for these products. What is included in the new revision? According to the EC, revision to the document has been made to reflect changes in regulatory and manufacturing environments.
Pharmacy Times
AUGUST 25, 2023
The digital cessation platform is the first FDA-cleared OTC device to help individuals quit smoking tobacco.
Drug Topics
AUGUST 24, 2023
A greater number of pharmacy audits are originating not only from third party payors, but also from various government agencies, such as Medicare and Medicaid.
Pharmaceutical Technology
AUGUST 25, 2023
Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
AUGUST 25, 2023
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry.
Pharmacy Times
AUGUST 25, 2023
The recent discovery could aid further research on the cause of Huntington’s disease and other inherited conditions.
Drug Topics
AUGUST 24, 2023
The Modernizing and Ensuring PBM Accountability Act, recently passed by the Senate Finance Committee, aims to regulate PBMs in the Medicare Part D, Medicare Advance, and Medicaid spaces.
Pharmaceutical Technology
AUGUST 25, 2023
The US Food and Drug Administration's recent accelerated approval of Pfizer's Elrexfio for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) has made a significant impact in the oncology community.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 25, 2023
A group of Nigerian, British, and U.S. doctors have discovered a genetic variant that increases the risk of Parkinson’s disease in people of African and mixed-African descent and is not seen in those with European ancestry, a finding that could improve treatment of the movement disorder in a vastly underserved population. “It could be a major mechanistic basis of Parkinson’s disease in African populations,” the researchers said in their paper , published this week in
Pharmacy Times
AUGUST 25, 2023
There is lots of information about matters of women's health online, both true and untrue, but pharmacists remain a credible source for educating women about health matters.
Drug Topics
AUGUST 21, 2023
Receiving the vaccine during pregnancy is cited as crucial for both confronting disproportionate infant vulnerability and easing the disease burden for new and expecting mothers.
European Pharmaceutical Review
AUGUST 25, 2023
The first US Food and Drug Administration (FDA)-approved biosimilar has been authorised to treat multiple sclerosis. Tyruko (natalizumab-sztn) is a biosimilar to Tysabri (natalizumab) injection for adults with relapsing forms of MS. Approval of Tyruko has been granted to Sandoz Inc. It is indicated for the following relapsing forms of MS: Clinically isolated syndrome – a single, first occurrence of MS symptoms Relapsing-remitting disease – in this type of MS, episodes of new neurological symptom
Fierce Pharma
AUGUST 24, 2023
Just a few short weeks after Wegovy posted a major cardio outcomes win, Novo Nordisk has chalked up another heart-related victory for its semaglutide star. | In a phase 3 study, semaglutide at the 2.4 mg dose bested placebo at reducing symptoms and physical limitations in patients with obesity and heart failure with preserved ejection fraction. The drug also led to greater improvements in exercise function and more weight loss versus a dummy drug, according to study results published in The New
Pharmacy Times
AUGUST 25, 2023
The FDA is the first regulatory agency globally to approve natalizumab-sztn as a biosimilar for natalizumab.
Drug Topics
AUGUST 21, 2023
A recent study found that Infants younger than 3 months, those born prematurely, and those who were publicly insured were at a higher risk for intubation.
The FDA Law Blog
AUGUST 24, 2023
Hyman, Phelps & McNamara, P.C. (“HP&M”) is is proud to announce that 14 of the Firm’s attorneys have been selected to the 2024 edition of The Best Lawyers in America®. Newly recognized this year are attorneys Josephine M. Torrente (FDA Law), Michelle L. Butler (FDA Law), Sara W. Koblitz (FDA Law), Allyson B. Mullen (FDA Law), and Anne K. Walsh (FDA Law), as well as McKenzie E.
The Checkup by Singlecare
AUGUST 24, 2023
Maybe you’ve heard that acidophilus is excellent for your gut health. Or perhaps a friend has recommended it as an immunity booster for fighting the cold or flu. The truth is that acidophilus—a beneficial bacteria found in your body, certain foods, and most probiotic supplements —has many health benefits. L. acidophilus probiotics can help your body in several ways, including aiding in weight loss, reducing cholesterol levels, and helping to treat vaginal infections.
Pharmacy Times
AUGUST 24, 2023
UB-311 has shown to be well-tolerated with a durable antibody response in a previous phase 1 trial, and new results from a phase 2a study support its continued development.
Drug Topics
AUGUST 24, 2023
A new study found that 34% of the chatbot’s answers included 1 or more recommendation that did not align with clinical guidelines.
Fierce Pharma
AUGUST 24, 2023
It's not always a good thing when a drug developer stops a cancer trial. But in a recent case for Exelixis, a Cabometyx trial ended early because of an undeniable efficacy showing. | Exelixis' drug proved its worth in treating advanced pancreatic and extra-pancreatic neuroendocrine tumors, so much so that an independent board unanimously recommended an early stop.
Hospital Pharmacy Europe
AUGUST 24, 2023
A birch bark extract has been recommended by NICE for treating skin wounds associated with dystrophic and junctional epidermolysis bullosa. In the UK, draft guidance from NICE has recommended a birch bark extract within its marketing authorisation, as an option for treating partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in people aged 6 months and over.
Pharmacy Times
AUGUST 24, 2023
The drug is the first approved antiviral COVID-19 treatment that could be used across all stages of liver disease.
Drug Topics
AUGUST 22, 2023
The respiratory syncytial virus vaccine (Abrysvo) is the first and only maternal RSV vaccine used to help protect infants from the virus.
Expert insights. Personalized for you.
123 
Let's personalize your content